ERS International Congress, Milan 2017

Browse by day: Saturday, 09.09.2017 Sunday, 10.09.2017 Monday, 11.09.2017 Tuesday, 12.09.2017 Wednesday, 13.09.2017		Sponsored symposia: Industry Evening Symposium at ERS 2017: “Evolving Concepts in Asthma with Type 2 Inflammation: the Role of Biologics”

Citations should be made in the following way: Authors. Title. Eur Respir J 2017; 50: Suppl. 61, abstract number.

Oral Presentation
Chairs: F. Bonella (Dusseldorf, Germany), B. Crestani (Paris, France)

Late Breaking Abstract - Evaluation of the JNK inhibitor, CC-90001, in a phase 1b pulmonary fibrosis trial. S. Greenberg (Westfield, United States of America)
LSC - 2017 - Hippo-YAP/TAZ signaling is deranged in IPF D. Wagner (Lund, Sweden)
Retrospective analysis of microbiome in idiopathic pulmonary fibrosis. Y. Takahashi (Sapporo, Japan)
A genetic landscape of familial predisposition to sarcoidosis identified by whole exome sequencing A. Calender (Lyon, France)
The pathomechanistic role of autophagy in lung fibrosis P. Mahavadi (GIESSEN, Germany)
Nuclear miRNA/exosome-mediated transcriptional silencing within the context of TGFB1 signaling and Idiopathic Pulmonary Fibrosis. G. Barreto (Bad Nauheim, Germany)
The expression of miR185, miR29a and their targets in IPF and lung cancer (LC). A BALF study. E. Bibaki (Heraklion, Crete, Greece)